
Bloomberg
Biotech Visionary Is Skeptical About AI’s Impact on Medical Innovation
The inventor of the groundbreaking Crispr gene-editing technology is skeptical about artificial intelligence replacing human effort in the realm of scientific discovery, adding to a growing debate over its impact on medical research and innovation.
View original source — Bloomberg ↗
Related stories
TASS
BusinessJun 24, 2026 · 1 min
Brent prices down below $74/bbl on ICE first time since February 27
TASS
TASS
BusinessJun 24, 2026 · 1 min
Gold futures decline below $4,000 per ounce — market data
TASS

Bloomberg
BusinessJun 24, 2026 · 1 min
Milei Shuns Wall Street to Raise Dollars at Rate Lower Than 7%
Bloomberg

Portugal Resident
BusinessJun 24, 2026 · 1 min
Brazilian hospitality brand Fasano to open first Portugal hotel in Cascais
Portugal Resident